Abstract 5058
Background
Caregiving a cancer patient is a complex role that involves new responsibilities for which caregivers don’t feel ready to provide care. Caregivers who feel unprepared for giving care have physical, psychological and social problems. It is necessary to determine all the needs of caregivers.
Methods
This is cross-sectional descriptive study was carried out with 203 Turkish cancer family caregivers at the oncology wards of six hospital from January-March 2019. We defined a caregiver as one of the family members who give most assistance. Data were collected with “Preparedness Scale of the Family Care Inventory”. The scale consists of eight items, total score range is 0-32. Higher scores indicate that the caregiver feels more prepared for their role. Data were evaluated by independent groups t test, one-way analysis of variance test.
Results
The mean age of the caregivers was 46.8±13.8; most of them were female (64.5%); 68% of them felt constantly tired during the caregiving period; 55% had a decrease in social relations. Seventy one percent of the caregivers expressed that they wanted to know about the practices to protect their patients from infection; 64% of them wanted to know about what to do in case of emergency. Caregivers’ mean score from the scale was 27.0±6.0. Preparedness scores of those with high socioeconomic status are higher than those with low socioeconomic status (F = 4.047; p = 0.001). Less than one-year caregivers are more ready to provide care than caregivers for between one-five years; and between six-ten years caregivers are more ready to provide care than between one-five years (F = 6.464; p = 0.002).
Conclusions
Meeting caregiving needs is associated with high socioeconomic status. It is expected result that high socioeconomic status is related to preparedness for caregiving. Less than one-year caregivers encounter less problems. Nurses need to recognize that ’new’ cancer caregivers may be feeling difficulty when the problem is encountered. Caregivers with more experience duration develop the ability to solve care problems as the time to care for cancer patients increases. Nurses need to recognize that caregivers often are ’experienced’ caregivers may be feeling burnout and ignore their own health-related problems.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2728 - MicroRNA expression and DNA methylation profiles do not distinguish between primary and recurrent well-differentiated liposarcoma
Presenter: Melissa Vos
Session: Poster Display session 1
Resources:
Abstract
3197 - Genomic Alterations, Tumor Mutation Burden and Prognosis of Chinese Cardiac Sarcoma Patients
Presenter: Na Zhu
Session: Poster Display session 1
Resources:
Abstract
4214 - Evaluation of a peptide-conjugated alkylator melflufen in osteosarcoma preclinical models
Presenter: Konstantin Byrgazov
Session: Poster Display session 1
Resources:
Abstract
2654 - Expression analysis of NHEJ and HR genes in Ewing sarcomas: indications of DSB repair dysfunction
Presenter: Anastasios Kyriazoglou
Session: Poster Display session 1
Resources:
Abstract
4383 - Epidemiology of Synovial Sarcoma in EU28 countries
Presenter: Nedra Joseph
Session: Poster Display session 1
Resources:
Abstract
1937 - Resection Of High-Grade Large Soft Tissue Sarcoma With Adequate Wide Margin Can Lead To Good Local Control Without Adjuvant Radiotherapy
Presenter: Toshiyuki Kunisada
Session: Poster Display session 1
Resources:
Abstract
3757 - Influence of eribulin on proliferation, migration and invasion properties of leiomyosarcoma cell line models
Presenter: Marta Mendiola
Session: Poster Display session 1
Resources:
Abstract
1040 - EREMISS: Efficacy of regorafenib (REG) as maintenance therapy in non-adipocytic soft tissue sarcomas (STS) having received 1st-line doxorubicin-based chemotherapy (Doxo-CT)
Presenter: Nicolas Penel
Session: Poster Display session 1
Resources:
Abstract
1048 - A Phase 2 biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, a disease with a high unmet need
Presenter: Kan Yonemori
Session: Poster Display session 1
Resources:
Abstract
1511 - A pilot study of oral paclitaxel (ORAXOL) in subjects with cutaneous angiosarcomas (KX-ORAX-010)
Presenter: Herbert Loong
Session: Poster Display session 1
Resources:
Abstract